283 related articles for article (PubMed ID: 17198225)
21. Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: explanation and potential clinical applications for color-coded qualitative and quantitative analysis.
Wang L; Van den Bos IC; Hussain SM; Pattynama PM; Vogel MW; Krestin GP
Acta Radiol; 2008 Feb; 49(1):6-18. PubMed ID: 18210307
[TBL] [Abstract][Full Text] [Related]
22. MRI for identification of progression in brain tumors: from morphology to function.
Weber MA; Giesel FL; Stieltjes B
Expert Rev Neurother; 2008 Oct; 8(10):1507-25. PubMed ID: 18928344
[TBL] [Abstract][Full Text] [Related]
23. The value of dynamic MRI studies in parotid tumors.
Alibek S; Zenk J; Bozzato A; Lell M; Grunewald M; Anders K; Rabe C; Iro H; Bautz W; Greess H
Acad Radiol; 2007 Jun; 14(6):701-10. PubMed ID: 17502260
[TBL] [Abstract][Full Text] [Related]
24. Gadolinium contrast dose in the evaluation of central nervous system tumors.
Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Simonson TM; Nguyen HD
Neuroimaging Clin N Am; 1994 Feb; 4(1):81-8. PubMed ID: 8130954
[TBL] [Abstract][Full Text] [Related]
25. Contrast-enhanced MR imaging of the spine: when, why and how? How to optimize contrast protocols in MR imaging of the spine.
Colosimo C; Cianfoni A; Di Lella GM; Gaudino S
Neuroradiology; 2006 Apr; 48 Suppl 1():18-33. PubMed ID: 16699849
[TBL] [Abstract][Full Text] [Related]
26. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging.
Stoll G; Bendszus M
Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996
[TBL] [Abstract][Full Text] [Related]
27. Analysis of perfusion weighted image of CNS lymphoma.
Lee IH; Kim ST; Kim HJ; Kim KH; Jeon P; Byun HS
Eur J Radiol; 2010 Oct; 76(1):48-51. PubMed ID: 19500931
[TBL] [Abstract][Full Text] [Related]
28. Discrepancy between the dynamic computed tomography and T2 magnetic resonance perfusion imaging in brain tumors: a report of 2 cases.
Li YD; Geng DY; Zhang QB; Jiang SH
J Comput Assist Tomogr; 2007; 31(6):896-900. PubMed ID: 18043353
[TBL] [Abstract][Full Text] [Related]
29. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
[TBL] [Abstract][Full Text] [Related]
30. Cerebral perfusion abnormalities in children with Sturge-Weber syndrome shown by dynamic contrast bolus magnetic resonance perfusion imaging.
Evans AL; Widjaja E; Connolly DJ; Griffiths PD
Pediatrics; 2006 Jun; 117(6):2119-25. PubMed ID: 16740855
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
Hirschberg H; Wu GN; Madsen SJ
Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
[TBL] [Abstract][Full Text] [Related]
32. Molecular imaging with targeted contrast agents.
Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
[TBL] [Abstract][Full Text] [Related]
33. Hemorrhage detection during focused-ultrasound induced blood-brain-barrier opening by using susceptibility-weighted magnetic resonance imaging.
Liu HL; Wai YY; Chen WS; Chen JC; Hsu PH; Wu XY; Huang WC; Yen TC; Wang JJ
Ultrasound Med Biol; 2008 Apr; 34(4):598-606. PubMed ID: 18313204
[TBL] [Abstract][Full Text] [Related]
34. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
35. Gadofluorine M-enhanced magnetic resonance nerve imaging: comparison between acute inflammatory and chronic degenerative demyelination in rats.
Wessig C; Jestaedt L; Sereda MW; Bendszus M; Stoll G
Exp Neurol; 2008 Mar; 210(1):137-43. PubMed ID: 18061168
[TBL] [Abstract][Full Text] [Related]
36. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
37. High-resolution magnetic resonance imaging using gadolinium-based contrast agent for atherosclerotic carotid plaque.
Kawahara I; Morikawa M; Honda M; Kitagawa N; Tsutsumi K; Nagata I; Hayashi T; Koji T
Surg Neurol; 2007 Jul; 68(1):60-5; discussion 65-6. PubMed ID: 17586225
[TBL] [Abstract][Full Text] [Related]
38. Advanced MRI of adult brain tumors.
Young GS
Neurol Clin; 2007 Nov; 25(4):947-73, viii. PubMed ID: 17964022
[TBL] [Abstract][Full Text] [Related]
39. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
40. Dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the prostate.
Bonekamp D; Macura KJ
Top Magn Reson Imaging; 2008 Dec; 19(6):273-84. PubMed ID: 19512849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
